A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.

Tsiogkas, Sotirios G; Mavropoulos, Athanasios; Dardiotis, Efthimios; Zafiriou, Efterpi; Bogdanos, Dimitrios P

Tsiogkas, Sotirios G; Mavropoulos, Athanasios; Dardiotis, Efthimios; Zafiriou, Efterpi; Bogdanos, Dimitrios P.

Afiliação

Tsiogkas SG; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Mavropoulos A; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Dardiotis E; Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Zafiriou E; Department of Dermatology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Bogdanos DP; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Clin Exp Immunol ; 210(1): 79-89, 2022 10 21.

Article em En | MEDLINE | ID: mdl-35925616

Assuntos

Produtos Biológicos; Psoríase; Humanos; Leucócitos Mononucleares/metabolismo; Metotrexato; Células Th17/metabolismo; Psoríase/tratamento farmacológico; Psoríase/metabolismo; Interleucinas/metabolismo; Citocinas/metabolismo; Receptores CXCR3

Palavras-chave

IL-17; T cells; anti-IL-17; inflammation. psoriasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google